Does Alloy Prescribe Veozah?

Does Alloy prescribe Veozah right now?

No. Alloy publishes an educational article aboutVeozah, but Veozah does not appear on Alloy’s live treatment menu, and its listed non-hormonal medicine for hot flashes and night sweats is low-dose paroxetine — not Veozah. Writing about a drug is not the same as dispensing it.

Here’s what we found when we looked at Alloy’s actual product pages in July 2026. The menopause menu lists hormone options (estradiol pill, estradiol patch, Evamist estradiol spray, estradiol gel, vaginal cream) and one non-hormonal pill: paroxetine. Veozah isn’t there. Alloy’s Veozah content lives in its blog— a helpful explainer written by its chief medical advisor — but a blog post is education, not a checkout button.

One honesty note: we can confirm that Veozah is not on Alloy’s published menu today, and that Alloy’s care model isn’t built to prescribe it safely (more on the lab problem next). What we can’t do is promise no Alloy clinician would ever bring it up. Menus change. If Veozah is the whole reason you’re signing up, the smart move is to confirm with Alloy directly before you pay — and we give you a word-for-word script to do that further down.

The Alloy → Veozah check: what we could verify before you pay

This is the table we wish existed when we started. No single competing page combines these facts, dated, in one place.

Does Alloy order bloodwork for Veozah? Why it’s not the clean way to get it

The real issue isn’t that Alloy is a bad menopause company — it isn’t. The issue is fit. Veozah’s FDA label requires a liver blood test before the first dose, and Alloy states plainly that it does not order or facilitate lab tests. A medicine that can’t be started safely without labs, and a service that doesn’t do labs, simply don’t line up. See our full Veozah liver warning breakdown for the complete monitoring schedule.

Let’s put the two facts side by side, because this is the heart of the whole page.

On one side, Alloy’s help center says, in its own words, that you don’t need bloodwork to begin, and that it does notoffer or facilitate lab testing — its clinicians do not order bloodwork on your behalf. That’s a feature for most of what Alloy treats; skipping labs makes estrogen or paroxetine faster and cheaper to start.

On the other side, Veozah’s FDA prescribing information now includes a boxed warning — the FDA’s most prominent warning — for rare but serious liver injury. Because of it, the label says a clinician must run a liver panel (serum ALT, AST, ALP, and bilirubin) before you take your first tablet, and must not start Veozah if certain liver values are already too high. (ALT and AST are enzymes that rise when the liver is stressed; bilirubin is a waste product the liver clears.)

So for Veozah specifically, Alloy’s no-labs model is the wrong tool. Not because anyone did anything wrong — because the drug and the model don’t match.

Here’s the one honest trade-off you should weigh. Midi Health — the provider we point Veozah-seekers to below — does notgive you one flat, lock-it-in monthly price the way Alloy does. What you pay depends on your insurance, and a cash-pay visit runs $250 for the first visit and $150 for follow-ups. If a fixed bill you can budget to the penny is what matters most to you, Alloy’s flat model genuinely wins on that one point. But because Midi bills insurance and orders labs, it can actually get you to Veozah — a $550-plus-a-month medicine that legally needs liver testing — which a flat, no-labs catalog can’t. For this one drug, that trade is the entire point. And if a predictable flat price still matters more to you than Veozah itself, Alloy’s paroxetine (below) may be your better move.

If Veozah is specifically what you want: See whether it’s a fit and check your state with Midi →
A provider that lists Veozah and can order the liver labs it requires.

What Alloy does offer for hot flashes without hormones

Alloy’s listed non-hormonal treatment for hot flashes and night sweats is low-dose paroxetine — priced at $34.99 on Alloy’s page, plus a one-time $49 consult fee. It’s a real option, especially for women who can’t or don’t want to take estrogen. But it works differently from Veozah, helps about half of women, and shouldn’t be treated as the same thing. See our does Alloy take insurance guide for the full billing picture.

Paroxetine is a type of antidepressant called an SSRI (selective serotonin reuptake inhibitor). At a low dose, it’s used for hot flashes, not mood. Here’s the fine print worth getting right: paroxetine is an FDA-approved medicine, and the version approved specifically for menopausal hot flashes is a 7.5 mg dose sold as Brisdelle. Alloy’s page lists a low 10 mg dose of paroxetine for hot flashes and night sweats — so if the exact FDA-approved formulation matters to you, confirm it at checkout. Alloy’s own page cites the well-known figure that about 50% of womensee a drop in hot flashes and night sweats on low-dose paroxetine, often within 2–4 weeks.

One more price note, in the spirit of full honesty: Alloy’s paroxetine page shows “$34.99 / 1-month supply” in the price box but describes a “3-month supply” in the details lower on the same page. That’s Alloy’s own inconsistency, not ours — confirm the exact supply length at checkout before you pay.

The honest limits matter too. Paroxetine helps roughly half of women, and it works less well than hormone therapy for strong hot flashes. It shouldn’t be combined with tamoxifen (a common breast-cancer medicine), because paroxetine can interfere with how tamoxifen works — a real issue for many of the women who reach for non-hormonal options in the first place. And it’s an SSRI, so it carries the usual SSRI considerations. It is not Veozah, and it does not work the same way. See our full Veozah vs. paroxetine comparison.

Paroxetine vs. Veozah, at a glance

Never start, stop, switch, or combine prescription medicines based on a web page. A licensed clinician has to decide what’s right for your history and your other medications.

What is Veozah, and who is it really for?

Veozah is the brand name for fezolinetant, a non-hormonal prescription pill approved by the FDA for moderate-to-severe hot flashes and night sweats due to menopause. It is not estrogen, not progesterone, and not a controlled substance. It treats hot flashes and night sweats — not vaginal dryness, bone loss, low libido, or every menopause symptom. See our full Veozah guide for the complete picture.

Here’s how it works, in plain terms. When estrogen drops in menopause, a brain chemical called neurokinin B (NKB) starts over-firing the part of your brain that controls body temperature — and that misfire triggers hot flashes. Veozah is the first prescription treatment designed to specifically block neurokinin B, which calms that heat signal. It’s the first drug of its kind, approved May 12, 2023. The dose is one 45 mg tablet, once a day.

Because Veozah only treats hot flashes and night sweats, matching it to your symptoms matters. Here’s the boundary in one look.

Veozah may be worth asking about if you can’t use hormones (for example, a history of hormone-sensitive breast cancer, blood clots, or heart disease), or you simply prefer a non-hormonal route, and your main problem is hot flashes and night sweats — and you’re willing to do the required liver tests.

And one honest frame worth stating clearly: for women who cantake hormones, The Menopause Society says hormone therapy is still the most effective treatment for hot flashes. Non-hormonal medicines like Veozah and paroxetine exist mainly for women who can’t or won’t use hormones. So the first real question often isn’t “which non-hormonal drug” — it’s “should I be on hormones at all?”

Not sure whether you can take hormones — or whether Veozah is even right for you? Match your symptoms and history with Find My HRT Path →
About 90 seconds, free, and it flags when online care isn’t the right starting point.

Veozah’s boxed warning and the liver tests you can’t skip

Veozah carries an FDA boxed warning — the agency’s most serious — added in December 2024 for rare but serious liver injury. Because of it, liver blood tests are required, not optional: a full panel before your first dose, then monthly for the first three months, and again at months 6 and 9. Veozah is not a controlled substance, but this monitoring is exactly why how you get it matters as much as whether you get it.

This is the part Alloy’s older blog post doesn’t reflect — that post predates the boxed warning and describes the old testing rhythm. Here’s the current schedule, straight from the FDA label (revised February 2026).

Who should not take Veozah(from the FDA label): anyone with known cirrhosis, severe kidney disease or end-stage renal disease, or who takes certain “CYP1A2 inhibitor” medicines (your clinician will screen for these). It hasn’t been studied in pregnancy or breastfeeding, so it isn’t for that.

Stop Veozah right away and call your clinicianif you notice new tiredness, loss of appetite, nausea, vomiting, itching, yellow skin or eyes, pale stools, dark urine, or belly pain — these can be signs of liver injury.

Common side effects (reported in at least 2% of women in trials): belly pain, diarrhea, trouble sleeping, back pain, hot flashes, and rises in liver enzymes.

None of this makes Veozah a bad drug. For the right woman, it’s a genuine step forward — the first non-hormonal option built to block the brain signal behind hot flashes. It just means Veozah needs a provider who can order labs, read them, and follow up. So a Veozah-ready online path really looks like this:

1. Order your baseline liver panel and review it before writing the prescription.
2. Send the script to a local pharmacy so you can use insurance or the manufacturer savings card.
3. Set the month 1, 2, 3, 6, and 9 lab reminders and review each result.
4. Have a clear “stop and call” plan if liver symptoms show up.
5. Help with prior authorization and the savings card so cost doesn’t stall you.

That single checklist is why a no-labs, cash-only catalog isn’t the right home for this drug — and why the provider you pick next actually matters.

How much does Veozah cost in 2026, and will insurance help?

Veozah is expensive without coverage — roughly $550 to $778 a month for a 30-day supply, with no generic available (the patent runs to 2034). But that’s the sticker price, not what most women with insurance actually pay. With commercial insurance, Astellas’ savings card can drop the cost to as little as $0 for the first month and $30 per refill, up to $4,000 a year — though it’s not valid with Medicare or Medicaid. See our dedicated Veozah cost without insurance guide for the full pharmacy-side breakdown.

Veozah price snapshot (verified July 2026)

• Cash / retail: about $550–$778 a month (varies by pharmacy and location).
• Manufacturer list price: about $566.50 (GoodRx, as of January 2025).
• Discount card (SingleCare): as low as about $474 with a coupon (can’t be combined with insurance).
• Commercial insurance + Astellas savings card: as little as $0 first month, then about $30 per refill, up to $4,000/year — commercial insurance only. See our Veozah savings card guide for the fine print.
• No generic exists, so prices stay high across the board.

Here’s the real picture by coverage type.

If cost is your barrier, run this quick insurance and prior-authorization checklist before you commit:

• Is Veozah on my plan’s formulary? Check your plan’s drug list, or ask the prescriber’s office to check.
• Does my plan require prior authorization or “step therapy”? For Veozah, both are common — step therapy means trying a cheaper option first.
• Do I have commercial insurance? If yes, get the Astellas savings card ($0 first month, ~$30 refills). It’s the single biggest lever.
• Am I on Medicare or Medicaid? The savings card won’t work — call Veozah Support Solutions for assistance options.
• Uninsured? Ask about the patient-assistance program, and compare GoodRx and SingleCare at a few pharmacies (prices swing $100+ between them).

And because coverage is where the real money is decided, the provider you choose matters. A cash-pay, no-insurance service generally isn’t the right model to run a Veozah prior authorization. A provider that bills insurance is more likely to support that — just ask directly whether they handle Veozah prior authorization before you book.

If Alloy can’t, where can you get Veozah online?

To get Veozah online you need a provider that does three things: lists (and can prescribe) it, orders the required liver labs, and — ideally — bills your insurance, because the cash price is steep. Midi Health is the cleanest match we verified: it lists fezolinetant (Veozah) among its non-hormonal options, orders labs through Labcorp, works with most PPO plans, and is available in all 50 states.

Here’s how the main online options actually compare — grounded in what each provider states, not guesses.

Best verified match for a Veozah conversation: Midi Health

We point Veozah-seekers to Midi for concrete, checkable reasons — not because it pays the most (it isn’t our highest-paying partner), but because it’s the one that actually fits this drug. See our full Midi Health review for more.

• Midi lists fezolinetant (Veozah) among its non-hormonal options for hot flashes, alongside SSRIs and SNRIs. (Formularies change — confirm Veozah at booking.)
• Midi orders labs (it generally uses Labcorp’s drop-in locations), so the liver panel Veozah requires is built into the care, not left to you.
• Midi is in-network with most PPO plans. With insurance, you pay your plan’s usual cost-sharing (a copay or deductible) — patients often report low copays. Without insurance, Midi’s visits are $250 for the first visit and $150 for follow-ups.
• Midi is available in all 50 states, with menopause-trained clinicians and live video visits. It has treated more than 230,000 patients.

One access note women appreciate. A patient testimonial published on Midi’s site reads: “Midi was incredibly easy. I signed up and had a visit the next day … By the end of the day, I had my prescriptions called in.” That speaks to the ease of access— not to whether any medicine is right for you, and results vary from person to person.

Two honest limits on Midi: it is not covered by Medicare or any Medicare-related plan (Medicare beneficiaries can be seen self-pay, but can’t file claims for visits, medications, or related services), and it cannot treat Medicaid or Medi-Cal patients, even self-pay. If that’s you, an in-person clinician is the cleaner route.

A lower-cost membership to check: Sesame

If you want a lower monthly membership model, Sesame Careoffers menopause care that includes labs and both hormonal and non-hormonal medicines, and its content discusses Veozah. Treat Veozah availability there as “confirm before you buy” — verify with Sesame support that a clinician will actually prescribe Veozah and how the labs are handled, rather than assuming it from a general “non-hormonal medications” mention.

The manufacturer’s own telehealth route

Veozah’s official site (veozah.com) offers a third-party telehealth path. Fair warning from Astellas itself: that clinic is separate from Astellas, you pay the third party, and there’s no guarantee any clinician will prescribe Veozah. It’s an option, not a shortcut.

When in-person care is the better first stop

Skip online-only and see a clinician in person if you have known liver disease or cirrhosis, severe kidney disease, a complex medication list, an active cancer diagnosis or treatment plan, new or severe symptoms, or you need insurance prior authorization handled by an established clinician who already knows your history.

Ready to talk Veozah with a provider that lists it and orders your labs? Check Midi’s availability in your state →
Ask how they handle Veozah coverage and prior authorization.

Veozah vs. Lynkuet: the newer non-hormonal option

There’s now a second non-hormonal drug in this class. Lynkuet (elinzanetant), from Bayer, was FDA-approved in October 2025. It blocks two brain receptors (NK1 and NK3) where Veozah blocks one, and it’s been studied in women taking endocrine (anti-estrogen) therapy for breast cancer — a group Veozah’s original trials didn’t include. Its liver-testing schedule is also lighter than Veozah’s: a baseline liver panel, then a single follow-up at 3 months, and no boxed warning. Both drugs are brand-only with no generic. See our full Veozah vs. Lynkuet comparison.

If you’re weighing non-hormonal options, Lynkuet is the newest one to raise with a prescriber. Here’s the quick comparison.

The takeaway: neither is a hormone, both need real liver monitoring and a prescriber conversation, and the right pick depends on your symptoms, your history, and cost. Which — again — is a conversation, not a checkout button.

Should you use Alloy anyway? A quick decision guide

Use Alloy if you want one of its clearly listed menopause treatments — its FDA-approved hormone options or its paroxetine — and you’re fine with a cash-pay, no-labs model. Don’t make Alloy your Veozah plan unless Alloy confirms it can evaluate, prescribe, and monitor Veozah, which its published model doesn’t support today.

A 20-second decision guide

1. Do you specifically want Veozah? Yes → use a lab-capable provider (like Midi), or confirm with Alloy first. No → Alloy may fit if its listed options match your symptoms.
2. Are you willing to do liver labs on schedule? Yes → choose a provider that orders labs. No → Veozah probably isn’t the medicine to chase.
3. Are you on Medicare or Medicaid, or counting on a savings card? Yes → check the rules before paying for any consult (the savings card excludes government insurance; Midi can’t bill Medicare or treat Medicaid). No → compare cash vs. insurance routes.

If you’re still on the fence about which route is safest for yoursituation, that’s exactly what our matching tool is for — and it’s free.

What to ask Alloy before you pay

If Veozah is the reason you’re considering Alloy, ask a few direct yes/no questions beforeyou pay the consult fee. The goal is simple: don’t pay to find out a service can’t give you the medicine and monitoring you actually want.

Copy-paste this to Alloy support:
“Hi — I’m considering Alloy because I’m interested in Veozah (fezolinetant) for hot flashes. Before I pay for a consult, can you confirm whether Alloy clinicians currently evaluate and prescribe Veozah when appropriate? If yes, how are the required baseline and follow-up liver blood tests ordered and reviewed? Can the prescription go to a local pharmacy so I can use insurance or the manufacturer savings card? And if Veozah isn’t available through Alloy, is the consult fee refundable?”

Answers that mean “go ahead”:they confirm Veozah is available, they explain how labs get ordered and reviewed, they can send the script to your pharmacy, and they’re clear about cost before you pay.

Answers that mean “choose another route”:“We don’t prescribe Veozah,” “We don’t order or review labs,” “We can’t send to your pharmacy,” or “You have to pay first to find out.” If you hear any of those, a lab-capable provider is your cleaner path — and Find My HRT Path can point you there.

How The HRT Index verified this

We built this page under The HRT Index Verification Standard — our documented process: read every published price, separate FDA-approved from compounded, confirm state availability and insurance, and re-check on a fixed schedule. We weigh providers on five things, in this order: clinical legitimacy, care quality, medication fit, price transparency, and access. This page is editorial research, not medical advice, and it is not reviewed by a clinician.

What we checked for this page (July 2026)

• Alloy’s live treatment menu and paroxetine page (price, consult fee, HSA/FSA).
• Alloy’s own help-center statement that it does not order or facilitate labs.
• Veozah’s FDA prescribing information for the boxed warning, lab schedule, and contraindications (label revised February 2026).
• Veozah’s 2026 cash prices, discount-card prices, coverage data, and savings-card terms (GoodRx, SingleCare, Astellas).
• Lynkuet’s FDA label (Bayer, October 2025).
• Midi’s public listing of fezolinetant plus its lab and insurance model.

What still deserves your own check before you commit

• Ask Alloy directly whether it prescribes Veozah in your state today.
• Confirm Veozah with Midi at booking (formularies change).
• Verify Veozah’s current cash price and savings-card terms on the day you fill, since drug prices move.

Who made this and why: This page was written by The HRT Index editorial team — the independent menopause HRT decision layer for women — to help you decide whether Alloy is the right path for Veozah beforeyou pay for a consult. It’s editorial research, not medical advice, and it was not reviewed by a clinician. We’re transparent about what we checked and when, and we re-verify pricing monthly and medical and regulatory facts quarterly.

Frequently asked questions

The short version: Alloy doesn’t currently list Veozah and doesn’t order the labs it requires. These answers cover the follow-ups most likely to send you back to searching.

So — does Alloy prescribe Veozah?

No, not today. If Veozah is specifically what you want, Alloy’s no-labs, cash-pay model isn’t built to get you there safely — you’ll need a provider that lists Veozah and orders the required liver labs, like Midi. If your main problem is hot flashes and you’re open to Alloy’s listed paroxetine or its hormone options, Alloy may still be a reasonable fit. If you’re unsure whether Veozah, hormone therapy, a local treatment, or in-person care fits you, don’t guess. Take our free Find My HRT Path match. It takes about 90 seconds and gives you a personalized starting point — including a flag if your situation calls for in-person care — before your first consult.

The HRT Index is the independent decision resource for online menopause and HRT care. Educational only — not medical advice. FDA-approved and compounded medications are always labeled distinctly, and compounded options are never implied to be equivalent to FDA-approved medicine. Some providers may compensate The HRT Index if you click or apply; our recommendations follow The HRT Index Verification Standard, not payout. Because Find My HRT Path collects sensitive health information, it’s handled under our consumer-health-data and privacy policy. For any medical decision, talk with a licensed clinician. Last verified: July 2026.

Sources (verified July 2026)

• Alloy — treatment menu and low-dose paroxetine page (price $34.99; one-time $49 consult fee; HSA/FSA; ~50% response) — accessed July 2026
• Alloy — Help Center: “Do I need bloodwork or lab tests to use Alloy’s services?” (“we also do not offer or facilitate lab testing, and our clinicians do not order bloodwork on your behalf”) — accessed July 2026
• Alloy — educational Veozah article (chief medical advisor)
• FDA / DailyMed — VEOZAH (fezolinetant) prescribing information: boxed warning (hepatotoxicity, added 12/2024); baseline + follow-up liver labs (ALT/AST/ALP/bilirubin; monthly first 3 months, months 6 and 9); contraindications (cirrhosis; severe renal impairment/ESRD; CYP1A2 inhibitors); DEA schedule: none. Label revised 2/2026
• FDA — Drug Safety Communication: boxed warning for serious liver injury (Dec 16, 2024)
• FDA — approval announcement (May 12, 2023)
• Veozah.com — efficacy (~63% fewer hot flashes at 12 weeks vs ~42% placebo) and Savings Card terms ($0 first month/$30 refills; up to $4,000/yr; commercial insurance only)
• Veozah 2026 pricing and coverage — GoodRx (list price ~$566.50 as of Jan 2025; nearly all Medicaid plans, close to 70% commercial, nearly 60% ACA plans cover it) and SingleCare (retail/coupon) — accessed 2026
• Midi Health — non-hormonal options including fezolinetant; orders labs (Labcorp); all 50 states; PPO insurance; not covered by Medicare; can’t treat Medicaid; self-pay $250 initial / $150 follow-up; 230,000+ patients; patient testimonial — joinmidi.com and Midi HRT / insurance page
• Sesame Care — menopause membership includes labs and hormonal/non-hormonal medications — sesamecare.com
• Lynkuet (elinzanetant) — Bayer FDA-approval announcement (Oct 2025): dual NK1/NK3; baseline hepatic panel + follow-up at 3 months; contraindicated in pregnancy; CNS/daytime impairment; seizure caution; CYP3A4 interactions
• The Menopause Society — 2023 nonhormone therapy position statement (hormone therapy most effective for hot flashes; non-hormonal options for those who can’t/won’t use hormones)